Chemours (CC) Financials, Dividends & Stock Info
Explore comprehensive financial data for Chemours, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (519 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Chemours (CC) is a diversified chemicals company. The company reports annual revenue of $5.8B and net loss of $238M. Its profit margin is -4.1%.
Chemours Key Financials
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Chemours Financial Health ScoreFY2025
Weak financial health; requires careful evaluation
-3 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
About Chemours
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
- Industry
- Diversified Chemicals
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Thin Marginsvs 4.8% sector median / 8.3% avg
Currently operating at a loss of 4 cents per dollar of revenue.
Profit margin 150% below sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Chemours 10-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B(+0.4%) | $5.8B(-4.9%) | $6.1B(-11.0%) | $6.8B(+7.7%) | $6.3B(+27.7%) | $5.0B(-10.1%) | $5.5B(-16.8%) | $6.6B(+7.4%) | $6.2B(+14.5%) | $5.4B(-5.5%) |
| Net Income | $-339,000,000(-591.3%) | $69.0M(+127.3%) | $-253,000,000(-143.8%) | $578.0M(-4.9%) | $608.0M(+177.6%) | $219.0M(+521.2%) | $-52,000,000(-105.2%) | $995.0M(+33.4%) | $746.0M(+10557.1%) | $7.0M(+107.8%) |
| Total Assets | $7.4B | $7.5B | $8.2B | $7.6B | $7.5B | $7.1B | $7.3B | $7.4B | $7.3B | $6.1B |
| Total Debt | $4.1B | $4.1B | $4.0B | $3.6B | $3.7B | $4.0B | $4.0B | $4.0B | $4.1B | $3.6B |
| Total Equity | $566.0M | $571.0M | $721.0M | $1.1B | $1.1B | $813.0M | $689.0M | $1.0B | $860.0M | $100.0M |
| Profit Margin | -5.8% | 1.2% | -4.2% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% | 0.1% |
| ROE | -59.9% | 12.1% | -35.1% | 52.2% | 56.2% | 26.9% | -7.5% | 98.1% | 86.7% | 7.0% |
| ROA | -4.6% | 0.9% | -3.1% | 7.6% | 8.1% | 3.1% | -0.7% | 13.5% | 10.2% | 0.1% |
Quarterly Financials
Last 8 quarters| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - |
| Total Assets | - | - | - | $7.5B | $7.2B | $8.0B | $7.9B | $7.7B |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Chemours Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerThis company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: -15.7%.
Annual Dividends
2017 - 2025| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $0.29 | $0.67 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $0.42 |
| YoY Growth | - | +131.0% | +49.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -57.5% |
| Payments | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Increased | - | Yes | Yes | No | No | No | No | No | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Chemours Free Cash Flow & Dividend Coverage
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $594.0M | $640.0M | $1.1B | $650.0M | $807.0M | $814.0M | $755.0M | $556.0M | -$633.0M | -$19.0M |
| CapEx | -$338.0M | -$411.0M | -$498.0M | -$481.0M | -$267.0M | -$277.0M | -$307.0M | -$370.0M | -$360.0M | -$213.0M |
| Free Cash Flow | $256.0M | $229.0M | $642.0M | $169.0M | $540.0M | $537.0M | $448.0M | $186.0M | -$993.0M | -$232.0M |
| FCF Margin | 4.7% | 3.7% | 9.7% | 3.1% | 10.9% | 8.5% | 6.6% | 3.1% | -17.2% | -4.0% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Chemours Risk Factors
Common risks for Materials
Risk factors shown are common to the Materials and may not reflect all risks specific to CC. See SEC filings for complete disclosure.
Chemours FAQ
What is Chemours's annual revenue?
Chemours (CC) reported $5.8 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Chemours profitable?
Chemours reported a net loss with a -4.1% profit margin, totaling $238 million in net losses (TTM). All figures from SEC EDGAR 10-K filings.
Does Chemours pay dividends?
Yes, Chemours pays regular dividends. View the full dividend history and payout analysis on this page.
What is Chemours's financial health score?
Chemours has a financial health score of 40/100 (Grade: F), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Chemours financial data are available?
10 years of financial data are available for Chemours from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.